Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€52.44 Billion ≈ $61.30 Billion USD) by net assets (€1.30 Trillion ≈ $1.52 Trillion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Richter Gedeon Vegyészeti Gyár Nyilvános carry for a breakdown of total debt and financial obligations.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Universal Display
NASDAQ:OLED
|
0.056x |
|
Jiangsu Xinquan Automotive Trim Co Ltd
SHG:603179
|
0.013x |
|
Asia Commercial Bank
VN:ACB
|
0.522x |
|
PriceSmart Inc
NASDAQ:PSMT
|
0.055x |
|
Knife River Corporation
NYSE:KNF
|
0.156x |
|
Novanta Inc
NASDAQ:NOVT
|
0.011x |
|
Cochlear Ltd
AU:COH
|
0.065x |
|
Yuhan Corp.
KO:000100
|
0.035x |
Annual Cash Flow Conversion Efficiency for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (2013–2024)
The table below shows the annual cash flow conversion efficiency of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see RIG2 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €1.30 Trillion ≈ $1.52 Trillion |
€279.37 Billion ≈ $326.61 Billion |
0.214x | +67.87% |
| 2023-12-31 | €1.14 Trillion ≈ $1.34 Trillion |
€145.84 Billion ≈ $170.50 Billion |
0.128x | -26.81% |
| 2022-12-31 | €1.06 Trillion ≈ $1.24 Trillion |
€184.93 Billion ≈ $216.20 Billion |
0.174x | +15.06% |
| 2021-12-31 | €923.02 Billion ≈ $1.08 Trillion |
€139.90 Billion ≈ $163.56 Billion |
0.152x | -7.60% |
| 2020-12-31 | €813.94 Billion ≈ $951.58 Billion |
€133.52 Billion ≈ $156.10 Billion |
0.164x | +21.07% |
| 2019-12-31 | €724.87 Billion ≈ $847.45 Billion |
€98.21 Billion ≈ $114.82 Billion |
0.135x | -7.41% |
| 2018-12-31 | €685.75 Billion ≈ $801.71 Billion |
€100.34 Billion ≈ $117.31 Billion |
0.146x | +16.02% |
| 2017-12-31 | €664.02 Billion ≈ $776.31 Billion |
€83.75 Billion ≈ $97.91 Billion |
0.126x | +11.08% |
| 2016-12-31 | €681.87 Billion ≈ $797.18 Billion |
€77.42 Billion ≈ $90.51 Billion |
0.114x | -26.13% |
| 2015-12-31 | €618.39 Billion ≈ $722.96 Billion |
€95.05 Billion ≈ $111.12 Billion |
0.154x | +38.81% |
| 2014-12-31 | €561.73 Billion ≈ $656.72 Billion |
€62.20 Billion ≈ $72.72 Billion |
0.111x | -17.46% |
| 2013-12-31 | €551.20 Billion ≈ $644.41 Billion |
€73.94 Billion ≈ $86.45 Billion |
0.134x | -- |
About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the tr… Read more